Physician profile
Jarod Patrick Mcateer
NPI 1992947634
$536.26
in general payments reported to CMS, 2019-2025
13 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Pediatric Surgery provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.54 · 2022: $121 · 2024: $86.50 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $168.47 | 2025 | Spy-Phi System |
| Bolder Surgical, LLC | $63.24 | 2022 | |
| Urgo Medical North America, LLC | $51.89 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Pacira Pharmaceuticals Incorporated | $33.91 | 2022 | |
| Atricure, INC. | $33.90 | 2024 | |
| Insulet Corporation | $30.78 | 2025 | Omnipod |
| Hologic Sales and Service, LLC | $29.23 | 2024 | Coolseal Generator |
| Paratek Pharmaceuticals, INC. | $23.96 | 2022 | |
| Tolmar, INC. | $23.62 | 2025 | Fensolvi |
| Ethicon US, LLC | $23.37 | 2024 | Stratafix, Ethicon |
| Azurity Pharmaceuticals, INC. | $20.45 | 2025 | Triptodur |
| Biomarin Pharmaceutical INC. | $17.54 | 2021 | |
| Solventum Corporation | $15.90 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarod Mcateer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.